RVV.CN
Revive Therapeutics Ltd.
Canadian SecCADEQUITY
DELAYED
Last price
0.03
▼ 0.00 (16.67%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
0.03
Prev close
0.03
Day high
0.03
Day low
0.03
Volume
268.00K
Market cap
—
P/E (TTM)
—
52W range
0.01 – 0.08
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
-16.67%
-15.3%
1M
-16.67%
-20.4%
3M
-16.67%
-19.8%
6M
+66.67%
+55.6%
YTD
+150.00%
+137.7%
1Y
+66.67%
+46.7%
3Y
-37.50%
-111.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | — |
| Operating revenue | $0 | $0 | $0 | $0 | — |
| Research & development | $144.81K | $1.11M | $3.58M | $15.16M | -87.0% |
| Selling, general & admin | $1.40M | $2.06M | $1.77M | $2.49M | -31.9% |
| Total operating expense | $1.65M | $3.29M | $5.52M | $17.83M | -49.8% |
| Operating income | -$1.65M | -$3.29M | -$5.52M | -$17.83M | +49.8% |
| Net interest income | -$2.30K | $38.69K | $64.61K | $52.80K | -105.9% |
| Pre-tax income | -$11.01M | -$5.62M | -$6.32M | -$17.81M | -96.0% |
| Net income | -$11.01M | -$5.62M | -$6.32M | -$17.81M | -96.0% |
| Net income to common | -$11.01M | -$5.62M | -$6.32M | -$17.81M | -96.0% |
| Basic EPS | -0.03 | -0.01 | -0.02 | -0.06 | -200.0% |
| Diluted EPS | -0.03 | -0.01 | -0.02 | -0.06 | -200.0% |
| EBIT | -$11.01M | -$5.60M | -$6.28M | -$17.74M | -96.7% |
| EBITDA | -$11.01M | -$5.60M | -$6.28M | -$17.74M | -96.7% |
| Basic shares | 419.71M | 380.48M | 339.37M | 319.76M | +10.3% |
| Diluted shares | 419.71M | 380.48M | 339.37M | 319.76M | +10.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $14.56K | $773.07K | $2.09M | $3.92M | -98.1% |
| Cash & short-term investments | $14.56K | $773.07K | $2.09M | $3.92M | -98.1% |
| Total current assets | $68.41K | $1.14M | $2.35M | $4.16M | -94.0% |
| Property, plant & equipment | $828 | $1.08K | $1.40K | $1.84K | -23.0% |
| Goodwill & intangibles | $0 | $9.38M | $11.72M | $12.50M | -100.0% |
| Total assets | $205.02K | $10.64M | $14.25M | $17.07M | -98.1% |
| Total current liabilities | $3.51M | $3.32M | $3.44M | $4.17M | +5.7% |
| Long-term debt | $66.87K | — | $60.00K | $60.00K | — |
| Total debt | $66.87K | $25.22K | $219.69K | $327.73K | +165.2% |
| Total liabilities | $3.66M | $3.40M | $3.60M | $4.46M | +7.5% |
| Retained earnings | -$77.20M | -$66.19M | -$60.57M | -$54.25M | -16.6% |
| Shareholder equity | -$3.46M | $7.23M | $10.65M | $12.60M | -147.8% |
| Working capital | -$3.45M | -$2.18M | -$1.08M | -$2.21K | -57.8% |
| Net tangible assets | -$3.46M | -$2.15M | -$1.07M | $102.72K | -61.0% |
| Shares issued | 425.21M | 418.56M | 357.65M | 321.42M | +1.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$11.01M | -$5.62M | -$6.32M | -$17.81M | -96.0% |
| Depreciation & amortisation | $248 | $328 | $434 | $578 | -24.4% |
| Stock-based compensation | $124.14K | $136.45K | $0 | $1.04M | -9.0% |
| Change in working capital | $602.75K | -$185.54K | -$747.61K | $3.54M | +424.9% |
| Operating cash flow | -$767.66K | -$3.29M | -$6.03M | -$13.06M | +76.7% |
| Investing cash flow | -$30.00K | $0 | — | $0 | — |
| Financing cash flow | $39.15K | $1.98M | $4.20M | $376.35K | -98.0% |
| Free cash flow | -$767.66K | -$3.29M | -$6.03M | -$13.06M | +76.7% |
| End cash position | $14.56K | $773.07K | $2.09M | $3.92M | -98.1% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | $0 | — | — |
| Operating revenue | $0 | $0 | $0 | $0 | $0 | — | — |
| Research & development | $0 | $0 | $0 | $0 | $0 | — | — |
| Selling, general & admin | $456.63K | $274.74K | $205.86K | $321.83K | $420.93K | — | +66.2% |
| Total operating expense | $461.63K | $280.48K | $218.11K | $334.81K | $480.59K | — | +64.6% |
| Operating income | -$461.63K | -$280.48K | -$218.11K | -$334.81K | -$480.59K | — | -64.6% |
| Net interest income | -$2.24K | -$2.82K | -$1.74K | -$1.58K | -$840 | — | +20.4% |
| Pre-tax income | -$506.50K | -$238.72K | -$281.75K | -$9.60M | -$577.18K | — | -112.2% |
| Net income | -$506.50K | -$238.72K | -$281.75K | -$9.60M | -$577.18K | — | -112.2% |
| Net income to common | -$506.50K | -$238.72K | -$281.75K | -$9.60M | -$577.18K | — | -112.2% |
| Basic EPS | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | — |
| Diluted EPS | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | — |
| EBIT | -$506.50K | -$238.72K | -$281.75K | -$9.60M | -$577.18K | — | -112.2% |
| EBITDA | -$506.46K | -$238.68K | -$281.70K | -$9.60M | -$577.12K | — | -112.2% |
| Basic shares | 435.68M | 435.68M | 429.30M | — | 418.56M | 418.56M | 0.0% |
| Diluted shares | 435.68M | 435.68M | 429.30M | — | 418.56M | 418.56M | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $12.66K | $12.88K | $20.95K | $14.56K | $46.42K | — | -1.7% |
| Cash & short-term investments | $12.66K | $12.88K | $20.95K | $14.56K | $46.42K | — | -1.7% |
| Total current assets | $149.33K | $128.88K | $113.25K | $68.41K | $111.80K | — | +15.9% |
| Property, plant & equipment | $687 | $734 | $781 | $828 | $890 | — | -6.4% |
| Goodwill & intangibles | — | — | — | $0 | $9.38M | $9.38M | — |
| Total assets | $281.77K | $261.38K | $249.81K | $205.02K | $9.63M | — | +7.8% |
| Total current liabilities | $4.15M | $3.85M | $3.60M | $3.51M | $3.54M | — | +7.9% |
| Long-term debt | $70.77K | $69.49K | $68.18K | $66.87K | $65.57K | — | +1.8% |
| Total debt | $70.77K | $69.49K | $68.18K | $66.87K | $65.57K | — | +1.8% |
| Total liabilities | $4.31M | $4.00M | $3.75M | $3.66M | $3.69M | — | +7.6% |
| Retained earnings | -$78.22M | -$77.72M | -$77.48M | -$77.20M | -$67.60M | — | -0.7% |
| Shareholder equity | -$4.02M | -$3.74M | -$3.50M | -$3.46M | $5.94M | — | -7.6% |
| Working capital | -$4.01M | -$3.72M | -$3.49M | -$3.45M | -$3.43M | — | -7.6% |
| Net tangible assets | -$4.02M | -$3.74M | -$3.50M | -$3.46M | -$3.44M | — | -7.6% |
| Shares issued | 435.68M | 435.68M | 435.68M | 425.21M | 418.56M | — | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$506.50K | -$238.72K | -$281.75K | -$9.60M | -$577.18K | -112.2% |
| Depreciation & amortisation | $47 | $48 | $46 | $62 | $62 | -2.1% |
| Stock-based compensation | $221.77K | $0 | $19.95K | $0 | $124.14K | — |
| Change in working capital | $282.15K | $226.23K | $49.41K | $74.90K | $394.13K | +24.7% |
| Operating cash flow | -$218 | -$8.07K | -$142.41K | -$6.02K | -$73.99K | +97.3% |
| Investing cash flow | $0 | $0 | $0 | $0 | $0 | — |
| Financing cash flow | $0 | $0 | $148.80K | -$25.85K | $65.00K | — |
| Free cash flow | -$218 | -$8.07K | -$142.41K | -$6.02K | -$73.99K | +97.3% |
| End cash position | $12.66K | $12.88K | $20.95K | $14.56K | $46.42K | -1.7% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.03
-13.79% from price
SMA 20
0.03
-9.09% from price
SMA 50
0.03
-13.19% from price
SMA 100
0.03
-21.87% from price
SMA 200
0.02
+1.42% from price
EMA 12
0.03
-10.83% from price
EMA 26
0.03
-11.46% from price
EMA 50
0.03
-13.66% from price
RSI (14)
44.9
Neutral
MACD (12,26,9)
-0.00
Hist -0.00
ATR (14)
0.00
11.43% of price
Realised vol 30D
196.5%
Annualised
Bollinger upper
0.03
20, 2σ
Bollinger lower
0.02
20, 2σ
50 / 200 cross
Golden
0.03 vs 0.02
Trend bias
Above 200
+1.42%
Risk profile
Beta vs SPY
-0.37
Less volatile than market
Correlation to SPY
-0.02
Largely independent
Realised vol 30D
196.5%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-64.3%
Peak to trough
Max drawdown 5Y
-99.1%
Peak to trough
ATR 14
0.00
11.43% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
International Strength Offsetting North America Weakness Could Be A Game Changer For Under Armour (UAA)
Simply Wall St. · 5m ago
Jim Cramer Argued It’s A New World For Palo Alto Networks & CrowdStrike Holdings
Insider Monkey · 10m ago
Newmont (NEM) Stock Looks Near Fair Value After A Strong Run
Simply Wall St. · 11m ago
Will Pega’s Free Responsible AI Tools Deepen Its Recurring Revenue Moat For Investors In PEGA?
Simply Wall St. · 11m ago
Jim Cramer Dismissed Market Reaction To Cisco Systems, Inc. (NASDAQ:CSCO) Following Earnings
Insider Monkey · 13m ago
Jim Cramer Doesn’t Think Home Depot Is Expensive Enough To Be Avoided
Insider Monkey · 19m ago
Jim Cramer Advised Being Patient & Buying Walmart Inc. (NASDAQ:WMT)’s Shares
Insider Monkey · 20m ago
Jim Cramer Discussed Ross Stores, Inc. (NASDAQ:ROST) & TJX
Insider Monkey · 21m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.